RUTHFULLY YOURS

When J Street expresses outrage at your choice for ambassador to Israel, there’s very good reason to think you made a good pick. So it is with David Friedman, Donald Trump’s selection for that post.

Friedman, a bankruptcy attorney, is a long-time friend of the president-elect. He served on Trump’s Israel advisory committee during the campaign.

Friedman’s views on Israel are sound and will be a breath of fresh air. He does not believe Israeli settlements are an obstacle to peace (they are an excuse) and he says that a “two-state solution” is not a priority for the U.S. (why should it be?).

Friedman predicts that, as ambassador to Israel, he will be working from Jerusalem. He calls that city “Israel’s eternal capital.”

Presidential candidates routinely speak in favor of moving the U.S. embassy from Tel Aviv to Jerusalem. It is, after all, Israel’s capital and therefore the seat of its government.

No president has moved the embassy. Donald Trump seems prepared to do so. His selection of Friedman reinforces this impression.

Here is a 16-point position paper that Friedman co-wrote for the Trump campaign. I can barely find an unsound sentence in it.

Highlights include:

A Trump Administration will ensure that Israel receives maximum military, strategic and tactical cooperation from the United States, and the MOU will not limit the support that we give. Further, Congress will not be limited to give support greater than that provided by the MOU if it chooses to do so. Israel and the United States benefit tremendously from what each country brings to the table — the relationship is a two way street [note: and it ain’t J Street].

The U.S. should veto any United Nations votes that unfairly single out Israel and will work in international institutions and forums, including in our relations with the European Union, to oppose efforts to delegitimize Israel, impose discriminatory double standards against Israel, or to impose special labeling requirements on Israeli products or boycotts on Israeli goods.

‘These Conservative Friends of Israel lunches are always special.

But this year feels extra special. Not only is this CFI’s biggest ever lunch, with over 800 people and over 200 Parliamentarians.

It is the first time that I have come here as Prime Minister and Leader of the Conservative Party.

And it is a special time, for we are entering the centenary year of the Balfour Declaration.On the 2nd of November 1917, the then Foreign Secretary – a Conservative Foreign Secretary – Arthur James Balfour wrote:

“His Majesty’s Government view with favour the establishment in Palestine of a national home for the Jewish people, and will use their best endeavours to facilitate the achievement of this object, it being clearly understood that nothing shall be done which may prejudice the civil and religious rights of existing non-Jewish communities in Palestine, or the rights and political status enjoyed by Jews in any other country.”

It is one of the most important letters in history. It demonstrates Britain’s vital role in creating a homeland for the Jewish people. And it is an anniversary we will be marking with pride. Born of that letter, and the efforts of so many people, is a remarkable country. No one is saying the path has been perfect – or that many problems do not remain.

Of course, people are correct when they say that securing the rights of Palestinians and Palestinian statehood have not yet been achieved. But we know they can be achieved. We in Britain stand very firmly for a two-state solution. And we know that the way to achieve that is for the two sides to sit down together, without preconditions, and work towards that lasting solution for all theirpeople.

None of this detracts from the fact that we have, in Israel, a thriving democracy, a beacon of tolerance, an engine of enterprise and an example to the rest of the world for overcoming adversity and defying disadvantages.

As most of us here know – and as I realised during my visit in 2014 – seeing is believing.

For it is only when you walk through Jerusalem or Tel Aviv that you see a country where people of all religions and sexualities are free and equal in the eyes of the law.

It is only when you travel across the country that you realise it is only the size of Wales – and appreciate even more the impact it has on the world.

It is only when you meet our partners in eradicating modern slavery – one of the main reasons I visited in 2014 – that you see a country committed to tackling some of the world’s most heinous practices.

And it is only when you witness Israel’s vulnerability that you see the constant danger Israelis face, as I did during my visit, when the bodies of the murdered teenagers, Naftali Frenkel, Gilad Shaer and Eyal Yifrah, were discovered.

So seeing isn’t just believing; it is understanding, acknowledging and appreciating.

That is why I’m so pleased that CFI has already taken 34 of the 74 Conservative MPs elected in 2015 to Israel.

We saw in that video what a powerful experience it can be. We are so grateful to the people in this room for making it happen – but, of course, there is more to do.

We meet at a moment of great change for our country. In the wake of the referendum, Britain is forging a new role for itself on the world stage – open, outward-looking, optimistic.

Israel will be crucial to us as we do that. Because I believe our two countries have a great deal in common.

As the Ambassador Mark Regev said, we have common values; we work together, on health, counter-terrorism, cyber security, technology; and we can help each other achieve our aims.

First, we both want to take maximum advantage of trade and investment opportunities, because we know enterprise is the key to our countries’ prosperity.

Our economic relationship is already strong. The UK is Israel’s second-largest trading partner. We are its number-one destination for investment in Europe, with more than 300 Israeli companies operating here. And last year saw our countries’ biggest-ever business deal, worth over £1 billion, when Israeli airline El Al decided to use Rolls Royce engines in its new aircraft.

We should celebrate that, we should build on that – and we should condemn any attempt to undermine that through boycotts. I couldn’t be clearer: the boycotts, divestment and sanctions movement is wrong, it is unacceptable, and this party and this government will have no truck with those who subscribe to it.

Our focus is the opposite – on taking our trading and investing relationship with Israel to the next level. That is why one of the first places Mark Garnier visited as a minister in the Department for International Trade was Israel.

Last week, Israel’s defense minister, Avigdor Lieberman, announced that Israel was working tirelessly to thwart Iranian weapons transfers to Hezbollah via Syria. For the first time, Lieberman hinted that in addition to sophisticated weaponry, Hezbollah was seeking to acquire WMDs. The defense minister also noted that Israel would operate to preserve its interests “without taking other circumstances or restrictions into account.” Presumably, this means that regardless of the prospects of Hezbollah-Iranian retaliation or the presence of a Russian anti-aircraft umbrella, Israel will continue to act when its interests are threatened.

Lieberman’s tough talk followed a series of Israeli strikes against military targets within Syria. The first targeted a Hezbollah weapons convoy travelling along the Beirut-Damascus highway while a second strike hit a Syrian military compound just outside Damascus housing elements of Syria’s 4th Armored Division. A third attack on December 7 targeted Mezzeh Air Base in western Damascus. A number of secondary explosions occurred following the attack indicating direct hits.

Assad’s propaganda outlet, Sana, as well as the Hezbollah-affiliated Al Mayadeen TV channel blamed Israel for the Mezzeh attack though the former claimed the strike was carried out with surface-to-surface missiles while the latter alleged that it was executed by fighter jets flying over “Lebanese airspace.”

Following the attacks, Arab media reported that Russia had warned Hezbollah, and by extension Iran, not to retaliate. Russia’s interest in Syria is to ensure the survival of its air and naval facilities centered in or near Latakia and Tartus. Putin has no interest in needlessly antagonizing the Israelis and any form of Iranian or Hezbollah retaliation serves no Russian purpose and may in fact, undermine Moscow’s goals.

Hezbollah was quick to deny the Arab media reports terming them “incorrect and completely invented.” Despite the fact that Hezbollah uses principally Russian weapons and is wholly subservient to Iranian interests, it continues to maintain the façade of an independent, indigenous “resistance” organization. That is why Arab media reports of Russian warnings to the terror group provoked an immediate temperamental response but it is likely that those media reports were accurate.

In Syria, Putin pulls the strings and but for Moscow’s intervention, Assad’s position would be extremely precarious. It is therefore likely that Russia put the kibosh on any thought of Hezbollah retaliation as that kind of action would antagonize Israel and run counter to Russian interests.

On Sunday, in a 60 Minutes interview with Leslie Stahl, Prime Minister Benjamin Netanyahu classified Israel’s relations with Russia as “amicable.” That description might be bit of an understatement. At a recent conference hosted by the Moscow State Institute of International Relations, Russia’s envoy to the Middle East and Africa, Deputy Foreign Minister Mikhail Bogdanov termed relations between Moscow and Jerusalem “at their highest point ever.”

“We will not recognize Israel because it will inevitably go away. And we will not backtrack on the option of armed struggle until the liberation of all Palestine.” — Khalil Al-Haya, Hamas senior official.

The abandonment of Gaza by Israel in 2005 drove the Palestinian vote for Hamas the next year. It also explains why many Palestinians continue to support Hamas — because they still believe that violence is the way to defeat Israel.

Hamas believes that Israel does not have the right to defend itself against rockets and terror attacks. It even considers Israel’s self-defense as an “act of terror.”

In yet another sign that exposes Hamas’s ongoing preparations to attack Israel, the movement last week held a drill with live ammunition in the northern Gaza Strip.

“What has been achieved so far is a small jihad, and the big jihad is still awaiting us.” — Palestinian Authority President Mahmoud Abbas. Abbas is convinced that his “diplomatic jihad” against Israel is no less effective than Hamas’s jihad of terrorism.

Yet even if Abbas manages to achieve reconciliation with Hamas, this move should not be seen as sign of pragmatism on the part of the Islamist movement. Under no circumstances will Hamas relinquish its policy of the destruction of Israel and its replacement with an Islamist state.

From Abbas’s point of view, Hamas’s terrorism will only increase the pressure on Israel to capitulate. Here Abbas has an ally in Hamas: to multiply jihads to force Israel to its knees.

The Palestinian Islamist movement, Hamas, which is currently celebrating the 29th anniversary of its founding, misses no opportunity to broadcast its stated reason for being: to wage jihad (holy war) in order to achieve its goal of destroying Israel. Those who allege that Hamas is moving toward pragmatism and moderation might take note.

Last week, tens of thousands of Palestinians took to the streets of the Gaza Strip to participate in rallies marking the anniversary of the founding of Hamas. As in previous years, the rallies were held under the motto of jihad and “armed resistance” until the liberation of all Palestine, from the Jordan River to the Mediterranean Sea. Another message that emerged loud and clear from the rallies: Hamas will never recognize Israel’s right to exist.

This year’s rallies once again also served as a reminder of the enormous popularity that Hamas continues to enjoy among Palestinians — not only in the Gaza Strip, but also in the West Bank, where supporters of the Islamist movement celebrated the occasion, but on a smaller scale and with a lower profile, out of fear of the Palestinian Authority (PA) and Israeli security forces.

Khalil Al-Haya, a senior Hamas official, outlined in a speech before his supporters in the Gaza Strip his movement’s strategy, namely to pursue the fight until the elimination of Israel. “We will not recognize Israel because it will inevitably go away,” he declared.

“And we will not backtrack on the option of armed struggle until the liberation of all Palestine. Since its establishment, Hamas has been — and will remain — a Palestinian Islamic national and resistance movement whose goal is to liberate Palestine and confront the Israeli project. The liberation of the Gaza Strip is just the first step toward the liberation of Palestine — all Palestine. There is no future for the Israeli entity on our homeland.”

Anxiety continues to roil through the pro-Israel world over a possible last-minute political move by the Obama administration that could permanently alter the Israeli-Palestinian geo-political landscape.

Forty-eight hours after the November 8 election, I flew to South Florida for a series of lectures and briefings organized by StandWithUs, NOVA Southeast University and other organizations as part of the State Department’s International Education Week, this to analyze the prospects regarding relations with Israel in the last weeks of the Obama administration. Everywhere, audiences were on the edge of their seats asking whether President Obama would take extraordinary passive or active steps in the United Nations Security Council (UNSC) to recognize a Palestinian state or impose a peace settlement, including a territorial mandate following the lines of the 1948 truce. Unlike General Assembly resolutions, which are not binding, the UNSC generally creates lasting pillars of international law.

As we approach Noon, January 20, 2017, uncertainty continues to abound among even the most astute of political insiders.

President Barack Obama remains personally silent. Administration assurances in recent days proffer comfort to those hanging on every word to discern a course of action. But embedded ambiguities in each of those assurances only increases the speculation.

For example, in recent days, unnamed administration sources were quoted by the Associated Press suggesting that President Obama “has nearly ruled out any major last-ditch effort to put pressure on Israel over stalled peace negotiations with the Palestinians.” The phrase “nearly ruled out” shines brightly in that report to emphasize that no decision has been made.

A few days ago, America’s ambassador to Israel, Dan Shapiro, told Israel’s Army Radio that America “will always oppose one-sided initiatives,” adding that this position “is a long-term policy. Whenever there were one-sided initiatives, we opposed them in the past and we will always oppose them.” Skeptics note that “opposing” such a UN move is not the same as blocking it with a veto.

Those who know the administration best remain queasy that a sudden and unexpected move may play out in the UN Security Council in coming weeks. Obama has circumvented Congress on the Iran nuclear deal and many other issues where the President has explained he can unilaterally use his “phone and pen.” Among the un-reassured is House Foreign Relations Affairs Committee Chairman Ed Royce, R-Calif., who emphasizes Obama’s “unpredictability.”

Royce told an interviewer, “If you are heavily signaling that you’re not going to oppose and veto U.N. Security Council resolutions that seek to impose one-sided solutions, the consequence is others will take your measure, and the momentum will build, given the natural attitudes at the U.N.”

The most likely scenarios for Obama action in the UNSC are variations of the following three:

First: unilateral recognition of a Palestinian state within specified or approximate borders following the 1948 armistice lines where no Palestinian state ever existed. In virtually all world forums, this would more juridically move the status of Israel’s administrative presence in Judea and Samaria from disputed to occupation.
Second: abstain from vetoing a pending French resolution that would impose settlement lines and/or recognize a Palestinian state within 18 months absent agreement by the parties.
Third: impose a territorial settlement within a two-year deadline if the parties do not craft one themselves.

Any of the three measures would subtract the need for negotiations and bring Israelis and Palestinians closer to an entrenched stalemate.

The suspense has been intensified by developments in recent days.

1. In December, 2016, Israel is unprecedentedly integrated into the global economy, highlighting the successful battle against BDS (boycott, divestment and sanctions), while rejecting pessimism and fatalism.

2. According to a Bloomberg study: “An examination of foreign capital flow into Israel shows a near tripling from 2005 when the so-called BDS was started…. Israel’s economy is expected to grow 2.8% in 2016, compared with 1.8% for the US and the EU. In 2015, Israel’s industrial high-tech exports rose 13%, from 2014, to $23.7BN….”

3. 2016 is already a record year for total (mostly foreign) investments in Israel’s young high tech companies, exceeding the $4.4BN invested in 2015. For instance, Israel’s NeuroDerm, which develops drugs for central nervous system diseases, is expected to raise $75MN, on NASDAQ, by December 12, 2016. Some of the recent investments were made by the US-based Johnson & Johnson’s Development Corporation, the Australian Stock Exchange, the German medical equipment giant B. Braun Melsungen AG, China’s Internet giant Alibaba and Japan’s Sun Corporation.

4. A trilateral cooperation agreement has been concluded between Israel’s Mobileye – a collision avoidance sensor developer – Delphi Automotive, the UK-based global automotive parts manufacturer and the Silicon Valley-based Intel, aiming to manufacture a self-driving car by 2019. A similar partnership was struck between Mobileye, Intel and the German car giant, BMW.

5. A wave of acquisitions of Israeli companies by global giants persists, as evidenced by the November, 2016 acquisition of Israel’s valve repair device company, Valtech Cardio Ltd., by the Irvine, California-based Edwards Lifesciences Corp., for $340MN in stock and cash, in addition to $350MN in milestone payments over ten years and $300MN for Valtech’s research and development program. Just like 200-250 other (mostly US) major global hightech companies, Edwards has leveraged Israel’s brain-power by operating a research and development center in Israel, since the 2004 acquisition of Israel’s PVT for $90MN and milestone payments.

6. The London-based mega-billion-dollar Chinese/European XIO Group has acquired Israel’s Meitav-Dash Investment House for $400MN. In 2015, XIO acquired Israel’s medical device company, Lumenis, for $510MN. China’s telecommunications giant, Xinwei, is negotiating the acquisition of Israel’s Spacecom Satellite Communications for $190MN, reflecting the surging Chinese interest in the Israeli market and the significantly expanding Israel-China trade balance from $50MN in 1990 to $11BN in 2015, in addition to $15BN in acquisition of Israeli companies. The Hong Kong-based Rightleder Holding Group aims to acquire Israel’s sewage recycling (water purification) company, Advanced Membrane Separation. Also two Chinese capital funds, CDH and ZZ explore the acquisition of ironSource, Israel’s largest Internet company, for $1BN.

7. The Israel-India trade balance surged from $200MN in 1992 – when diplomatic relations were normalized – to $3BN in 2009 and $5BN in 2015, accompanied by a rise in two-way-tourism, paving the road to a negotiated free-trade-agreement, and highlighting India as one of Israel’s fastest growing trade partners in the commercial and defense areas. New Delhi has become the top customer for Israel’s defense industries, in addition to a series of co-development and co-production initiatives with Israel – in the face of joint economic and national security challenges – while Israel has become the number two/three exporter of military systems to India, following Russia and the USA.

8. On November 16, 2016, India signed $1.4BN contracts with the Israel Aerospace Industries (IAI), purchasing two additional Phalcon/IL-76 Airborne Early Warning and Control Systems and ten Heron unmanned aerial vehicles. IAI has submitted a proposal for the co-development, in India, of an advanced version of the Heron. The growing Israel-India defense ties are demonstrated by the recent Indian procurement of Rafael’s Gil anti-tank missiles, upgrades of Indian tanks by Elbit Systems and a joint development of the Barak-8 surface-to-air missile.

ISRAEL’S MEDICAL ACHIEVEMENTS

Key enzyme discovery in fight against cancer. Israel Technion researchers have found that the ubiquitin enzyme RNF4 binds to oncogenic proteins to give cancer cells longer lives. Increased levels of RNF4 have been found in colon and breast cancer patients. Removing or inhibiting RNF4 leads to the death of cancer cells.
http://www.technion.ac.il/en/2016/12/crucial-enzyme-for-tumor-development/
https://www.youtube.com/watch?v=yC53-lREHQg

Success in Sickle-Cell Disease trial. Israeli biotech Gamida Cell published positive results in its Phase I/II trial of NiCord, for the treatment of Sickle-Cell Disease (SCD). All the patients that completed the trial were free of SCD symptoms.
http://www.globes.co.il/en/article-gamida-reports-positive-nicord-results-1001165382

Full remission in Leukemia treatment trial. Israel’s BioSight has reported that in treating patients with its Astarabine leukemia treatment, three patients with late-stage leukemia achieved full remission to date. Good results were also reported for older patients over 80.
http://www.globes.co.il/en/article-biosight-completes-successful-cancer-drug-trial-1001165482

Sleep disorder treatment for autistic kids. Israeli biotech Neurim (featured Nov 20) has signed marketing agreements for its new Rx PedPRM treatment for sleep disorders in children with autism spectrum disorders and neurogenetic diseases. Kuhnil will market Rx PedPRM in Korea; Aspen in Australia and New Zealand.
http://www.neurim.com/news/2016-12-06/neurim-pharmaceuticals-paediatric-prolonged-release-melatonin-pedprm-to-be-marketed-by-kuhnil-pharmaceutical-in-south-korea/

Portable blood test for malaria. (TY Atid-EDI) Israel’s Sight Diagnostics (SightDx) (see here) in collaboration with the US Army Medical Research Directorate Kenya (USAMRD-K) is developing a portable malaria and complete blood count (CBC) reader. It will be calibrated and tested in clinical trials at the USAMRD-K Field Station in Kisumu, Kenya. http://www.prnewswire.com/news-releases/sight-diagnostics-ltd-and-the-united-states-army-announce-a-joint-collaboration-598337901.html

14 more hearts mended in Tanzania. Israeli surgeons from Save a Child’s Heart were back (again) in Tanzania, fixing another fourteen young, faulty hearts. The Israelis worked with a German team from Berlin’s Deutsches Herzzentrum during the five-day medical mission.
http://www.israel21c.org/israeli-german-medical-team-gives-14-children-gift-of-life/

Device to keep track of insulin doses. Israel’s Insulog is a device to help diabetes patients keep track of their insulin doses and prevent accidental overdoses. It snaps onto most types of disposable insulin pen, monitors and logs the dose and sends data to a smartphone app. It displays details of the last dose to the user.
Insulog is funding on Indiegogo. https://www.youtube.com/watch?v=0vscMWDcjlA
http://www.timesofisrael.com/israel-smart-tracker-aims-to-keep-tabs-on-insulin-shots/
https://www.indiegogo.com/projects/insulog-the-smart-snap-on-insulin-tracker-health–2#/

Israeli startup Insulog, which has created a device that helps diabetes patients keep track of their insulin doses, on Wednesday started a campaign to raise $50,000 via the crowdfunding platform Indiegogo.

The funds, said CEO and founder of the Ramat Gan-based firm Menash Michael, will help the company get the necessary US Food and Drug Administration and European permits to market the product. Contributors to the campaign will be able to get the product for $119, delivery of which will take place in summer 2017 when the approvals are in place, he said.

Diabetes patients who use an insulin pen to inject the hormone must remember to take the right dose at the right time, to help maintain stable sugar levels in the blood and to avoid over- or under-dosing, which could lead to life-threatening situations.

Even the most conscientious of patients can have a tough time managing the condition: they need to remember what they ate along with when they took their last dose of insulin and how many units they injected.

Indeed, Michael, who has suffered from Type 1 diabetes for over 30 years, ended up in the emergency room after he accidentally over-injected himself with insulin. After that experience, he came up with the idea for the smart, connected insulin tracker, the Insulog, to help diabetic patients like himself keep track of their medication regimen.

Smart sensors

The device, which snaps on to most types of disposable insulin pens, is equipped with smart sensors follow the pen vibrations and that reset each time a new dose of insulin is administered. An algorithm analyzes the clicks of the insulin pen, record the amounts taken and sends the information to a smartphone app. The pairing with the app enables users to view their entire injection history and share the information with their physician.

When the Insulog device is turned on for reuse, it displays data from the user’s most recent dose, showing when the last injection was administered and the quantity taken.

After his overdose, “now, I am hyper-alert of my insulin intake, and Insulog helps me to never make that mistake again,” said Michael, who founded the company in 2014. “There are hundreds of millions of people in the world who could greatly benefit” from the device, he said.